NCT02472522 is a NA clinical trial of Ropivacaine + Dexmedetomidine in Pregnancy, sponsored by Tata Main Hospital.

Who is sponsoring NCT02472522?

NCT02472522 is sponsored by Tata Main Hospital.

What drugs are being tested in NCT02472522?

Interventions in NCT02472522: Ropivacaine + Dexmedetomidine, Ropivacaine.

Is NCT02472522 still recruiting?

NCT02472522 is currently completed. Last updated 25 May 2016.

Are results published for NCT02472522?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2016-05-25 · How we verify

NCT02472522

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Study of Ropivacaine and Ropivacaine With Dexmeditomedine in Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia in Patients Undergoing Cesarean Sections

Completed NA Results posted Last updated 25 May 2016

What this trial tests

NA trial testing Ropivacaine + Dexmedetomidine in Pregnancy in 100 participants. Completed in 1 November 2015.

Timeline

1 May 2015

Primary endpoint
1 November 2015

1 November 2015

Quick facts

Lead sponsor	Tata Main Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	100
Start date	1 May 2015
Primary completion	1 November 2015
Estimated completion	1 November 2015
Sites	1 location across India

Drugs / interventions tested

Ropivacaine + Dexmedetomidine — full drug profile →
Ropivacaine (ROPIVACAINE) — full drug profile →

Conditions studied

Pregnancy — all drugs for Pregnancy →

Sponsor

Tata Main Hospital

Who can join

Adults 18 to 40, female only, with Pregnancy. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

The Time After the TAP Block When Rescue Analgesia Was First Sought
Time frame: 24 hours

Sponsor's own description

Comparative study of Ropivacaine and Ropivacaine with dexmedetomidine in transversus abdominis plane (TAP) block for post-operative analgesia in patients undergoing Caesarean Section.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparative Study of Ropivacaine and Ropivacaine With Dexmedetomidine in Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia in Patients Undergoing Cesarean Sections.
Nag DS, Gehlot P, Sharma P, Kumar H, et al · · 2024 · cited 1× · PMID 39192898 · DOI 10.7759/cureus.65588

Verify or expand the search:

Other trials of Ropivacaine + Dexmedetomidine

Trials testing the same drug.

NCT07290595 — Comparative Analysis Of Dexmedetomidine And Dexamethasone As An Adjuvant To 0.5%Ropivacaine On Onset Of Ultrasound Guide · Phase 2, PHASE3 · recruiting
NCT03809442 — Analgesic Efficacy of Ropivacaine Alone or in Combination With Adjuvants on Post-operative Analgesia Following Video-Ass · Phase 4 · completed

Other recruiting trials for Pregnancy

Currently open trials in the same condition.

NCT07405723 — Arm Position and Blood Pressure Measurement Accuracy During Pregnancy · NA · recruiting
NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07385807 — Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Out · recruiting
NCT07226492 — Cash Transfers to Pregnant Women With HIV · NA · recruiting
NCT07435766 — Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy · NA · recruiting

Other Tata Main Hospital trials

Trials by the same sponsor.

NCT07328893 — Effect of Single Dose Intravenous Magnesium Sulfate on Postoperative Analgesic Consumption in Patients Undergoing Laparo · Phase 4 · recruiting
NCT06602505 — Comparative Analysis of Incidence of Newly Developed Postoperative Low Back Pain with Field Block Versus Without Field-b · NA · completed
NCT05924230 — Dose Responsive Study of Ringer's Lactate Solution in Prevention of Post-induction Hypotension · NA · unknown
NCT06598566 — A Comparative Evaluation of Nottingham Hip Fracture Score (NHFS) and Acute Physiology and Chronic Health Evaluation (APA · completed
NCT04605952 — Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02472522 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tata Main Hospital
Last refreshed: 25 May 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02472522.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing